ArticleBone marrow transplantation2025

Letermovir prophylaxis may increase the risk of graft-versus-host disease after haploidentical hematopoietic stem cell transplantation with αβ

Dominik Turkiewicz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.